Business News

HOW TO SURVIVE A ZOMBIE (CELL) APOCALYPSE

[ad_1]

(ST. LOUIS, MO – December 21, 2022)CellFend, an innovative brand in the health and wellness industry, has released Fermented Long Pepper Extract, a patent pending, first of its kind nutritional supplement rich in piperlongumine, a unique bioactive molecule known for its anti-aging and senolytic properties. Senolytics are newly discovered molecules that can selectively kill senescent “zombie” cells, thereby promoting healthy aging.

Senescent “zombie” cells are cells that no longer divide and enter a permanent state of cell-cycle arrest (where they’re no longer part of a healthy cell cycle). Because they’re not actually living, yet they don’t die, they’re often nicknamed “zombie” cells. These cells release chemicals which act as poisons, causing damage to nearby healthy cells, facilitating a downward spiral, and triggering aging and age-related aliments. As we grow older, senescent cells accumulate in our bodies. This process is also known as Cellular Senescence.

“Senolytics are on the cutting edge of anti-aging science,” said Adam L. Sherman, CEO of CellFend. “There is well-documented research on the long pepper, piperlongumine, and their role in health, longevity, and senolytics. We’re excited to be bringing this product to market.”

CellFend’s Fermented Long Pepper Extract is available on their website at https://www.cellfend.com at $27 for a 1-month supply.

Research Data:

There are 350 results discussing the benefits and therapeutic potential of the molecule “piperlongumine” in the National Center for Biotechnology Information’s database:

https://pubmed.ncbi.nlm.nih.gov/?term=piperlongumine

About CellFend:

CellFend produces science-backed adjuvants & nutraceuticals, focusing on anti-aging and long-term cellular health. Their daily supplements are all single-ingredient, 100% natural plant extracts, fermented to increase the bioactive substances and bioavailability. All of their supplements are greater than 99%…

[ad_2]

Source link

Related Articles

Back to top button